The control of mumps in Israel.
BACKGROUND
Measles-mumps-rubella (MMR) vaccine replaced monovalent measles vaccine in the routine childhood vaccination schedule in Israel in December 1988, primarily to achieve the elimination of the congenital rubella syndrome. In this observational study, we report on changes in reported mumps incidence in Israel from the time of the introduction of MMR vaccine until the end of 1998.


METHODS
The report is based upon passive national surveillance of mumps incidence, which has been notifiable in Israel since 1977.


RESULTS
Reported mumps incidence in Israel is now less than 2% the pre-vaccine incidence.


CONCLUSIONS
In the decade since the introduction of routine mumps vaccination in 1-year-olds in Israel, mumps control has been achieved. Although small outbreaks occur and may continue to occur in future years, because of under-vaccination of children, primary vaccine failure and waning immunity, it can tentatively be said that mumps is no longer a public health problem in Israel.
Slater
P E
PE
Department of Epidemiology, Ministry of Health, Jerusalem, Israel.
Anis
E
E
Leventhal
A
A
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006801:Humans; D015994:Incidence; D007223:Infant; D007557:Israel / Q000453:epidemiology; D008875:Middle Aged; D009107:Mumps / Q000453:epidemiology* / Q000517:prevention & control